Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01510821 · ClinicalTrials.gov registry record · NA
Investigation of Endothelium in Saphenous Vein Grafts
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01510821 is a NA study that has completed, run by Emory University. The registered enrollment target is 30 participants.
The verdict
NCT01510821, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a single center prospective study of 30 patients undergoing elective heart bypass surgery (CABG) with at least two vein grafts from the leg (SVG). The purpose of this ex vivo study is to evaluate the function of vein grafts from small tissue samples treated with a pressure syringe and a non-pressure syringe. Syringes are routinely used to flush out the veins in preparation of bypass grafting. It is unknown if different levels of pressure in the syringe affect the vein or damage the vein. Small sections of tissue samples which are normally discarded will be obtained immediately after retrieval from the leg and before grafting to the heart. Tissue samples will be taken to the laboratory for study. There are no clinical endpoints in this study, however, clinical information will be obtained from the Society of Thoracic Surgeons database and will include demographics, risk factors, and perioperative outcomes.
Interventions
- OTHER Use of Maquet Vasoshield Pressure-limiting syringe on SVG
- OTHER Use of non-regulated syringe on SVG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01510821
The ClinicalTrials.gov registry entry for NCT01510821 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Use of Maquet Vasoshield Pressure-limiting syringe on SVG is the first listed.
NCT01510821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01510821 about?
NCT01510821 is a clinical study titled "Investigation of Endothelium in Saphenous Vein Grafts". This is a single center prospective study of 30 patients undergoing elective heart bypass surgery (CABG) with at least two vein grafts from the leg (SVG). The purpose of this ex vivo study is to evaluate the function of vein grafts from small tissue samples treated with a pressure syringe and a non-...
What is the current status of trial NCT01510821?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2011-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01510821?
The interventions under investigation include: Use of Maquet Vasoshield Pressure-limiting syringe on SVG (OTHER), Use of non-regulated syringe on SVG (OTHER).
Who is sponsoring clinical trial NCT01510821?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.